Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy

Carolina Echeverría, Francisco Nualart, Luciano Ferrada, Gary J. Smith, Alejandro S. Godoy*

*Autor correspondiente de este trabajo

    Producción científica: Contribución a una revistaArtículorevisión exhaustiva

    17 Citas (Scopus)


    Cancer cells increase their metabolic activity by enhancing glucose uptake through overexpression of hexose transporters (Gluts). Gluts also have the capacity to transport other molecules besides glucose, including fructose, mannose, and dehydroascorbic acid (DHA), the oxidized form of vitamin C. The majority of research studies in this field have focused on the role of glucose transport and metabolism in cancer, leaving a substantial gap in our knowledge of the contribution of other hexoses and DHA in cancer biology. Here, we summarize the most recent advances in understanding the role that the multifunctional transport capacity of Gluts plays in biological and clinical aspects of cancer, and how these characteristics can be exploited in the search for novel diagnostic and therapeutic strategies.

    Idioma originalInglés
    Páginas (desde-hasta)198-211
    Número de páginas14
    PublicaciónTrends in Endocrinology and Metabolism
    EstadoPublicada - 1 abr. 2021

    Nota bibliográfica

    Funding Information:
    This review article was supported by the Department of Defense ( W81XWH-12-1-0341 ) to A.G., PhD Fellowship Universidad de los Andes , Chile to C.E., Fondecyt 1181243 to F.N., and PIA-Conicyt ECM-12 to F.N.

    Publisher Copyright:
    © 2021 Elsevier Ltd


    Profundice en los temas de investigación de 'Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy'. En conjunto forman una huella única.

    Citar esto